Small Molecule Activators of Mitochondrial Fusion Prevent Congenital Heart Defects Induced By Maternal Diabetes

Overview

Journal JACC Basic Transl Sci

Date 2024 Apr 1

PMID 38559623

Authors

Guanglei Wang

Wenhui Lu

Wei-Bin Shen

Mariusz Karbowski

Sunjay Kaushal

Peixin Yang

Affiliations

Soon will be listed here.

Abstract

Most congenital heart defect (CHD) cases are attributed to nongenetic factors; however, the mechanisms underlying nongenetic factor-induced CHDs are elusive. Maternal diabetes is one of the nongenetic factors, and this study aimed to determine whether impaired mitochondrial fusion contributes to maternal diabetes-induced CHDs and if mitochondrial fusion activators, teriflunomide and echinacoside, could reduce CHD incidence in diabetic pregnancy. We demonstrated maternal diabetes-activated FoxO3a increases miR-140 and miR-195, which in turn represses Mfn1 and Mfn2, leading to mitochondrial fusion defects and CHDs. Two mitochondrial fusion activators are effective in preventing CHDs in diabetic pregnancy.

Citing Articles

Mitochondrial Targeted Therapies to Prevent Maternal Diabetes-Induced Congenital Heart Defects.

Reddy S JACC Basic Transl Sci. 2024; 9(3):319-321.

PMID: 38559633 PMC: 10978448. DOI: 10.1016/j.jacbts.2024.01.016.

References

Tuddenham L, Wheeler G, Ntounia-Fousara S, Waters J, Hajihosseini M, Clark I . The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells. FEBS Lett. 2006; 580(17):4214-7. DOI: 10.1016/j.febslet.2006.06.080. View

Yang P, Li X, Xu C, Eckert R, Reece E, Zielke H . Maternal hyperglycemia activates an ASK1-FoxO3a-caspase 8 pathway that leads to embryonic neural tube defects. Sci Signal. 2013; 6(290):ra74. PMC: 4768865. DOI: 10.1126/scisignal.2004020. View

Miret-Casals L, Sebastian D, Brea J, Rico-Leo E, Palacin M, Fernandez-Salguero P . Identification of New Activators of Mitochondrial Fusion Reveals a Link between Mitochondrial Morphology and Pyrimidine Metabolism. Cell Chem Biol. 2018; 25(3):268-278.e4. DOI: 10.1016/j.chembiol.2017.12.001. View

Li J, Li Y, Jiao J, Wang J, Li Y, Qin D . Mitofusin 1 is negatively regulated by microRNA 140 in cardiomyocyte apoptosis. Mol Cell Biol. 2014; 34(10):1788-99. PMC: 4019028. DOI: 10.1128/MCB.00774-13. View

Chen H, Detmer S, Ewald A, Griffin E, Fraser S, Chan D . Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol. 2003; 160(2):189-200. PMC: 2172648. DOI: 10.1083/jcb.200211046. View

Chen H, McCaffery J, Chan D . Mitochondrial fusion protects against neurodegeneration in the cerebellum. Cell. 2007; 130(3):548-62. DOI: 10.1016/j.cell.2007.06.026. View

Zhang G, Wang S, Chen Y, Fu L, Xu Y, Li L . MicroRNAs Regulating Mitochondrial Function in Cardiac Diseases. Front Pharmacol. 2021; 12:663322. PMC: 8194257. DOI: 10.3389/fphar.2021.663322. View

Mathews T, Driscoll A . Trends in Infant Mortality in the United States, 2005-2014. NCHS Data Brief. 2017; (279):1-8. View

Deng M, Zhao J, Tu P, Jiang Y, Li Z, Wang Y . Echinacoside rescues the SHSY5Y neuronal cells from TNFalpha-induced apoptosis. Eur J Pharmacol. 2004; 505(1-3):11-8. DOI: 10.1016/j.ejphar.2004.09.059. View

10.

Wren C, Birrell G, Hawthorne G . Cardiovascular malformations in infants of diabetic mothers. Heart. 2003; 89(10):1217-20. PMC: 1767924. DOI: 10.1136/heart.89.10.1217. View

11.

Botto L, Mulinare J, Erickson J . Occurrence of congenital heart defects in relation to maternal mulitivitamin use. Am J Epidemiol. 2000; 151(9):878-84. DOI: 10.1093/oxfordjournals.aje.a010291. View

12.

Li X, Du N, Zhang Q, Li J, Chen X, Liu X . MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy. Cell Death Dis. 2014; 5:e1479. PMC: 4237254. DOI: 10.1038/cddis.2014.430. View

13.

Ong S, Hall A, Hausenloy D . Mitochondrial dynamics in cardiovascular health and disease. Antioxid Redox Signal. 2012; 19(4):400-14. PMC: 3699895. DOI: 10.1089/ars.2012.4777. View

14.

Yang J, Cummings E, OConnell C, Jangaard K . Fetal and neonatal outcomes of diabetic pregnancies. Obstet Gynecol. 2006; 108(3 Pt 1):644-50. DOI: 10.1097/01.AOG.0000231688.08263.47. View

15.

Wang F, Wu Y, Quon M, Li X, Yang P . ASK1 mediates the teratogenicity of diabetes in the developing heart by inducing ER stress and inhibiting critical factors essential for cardiac development. Am J Physiol Endocrinol Metab. 2015; 309(5):E487-99. PMC: 4556884. DOI: 10.1152/ajpendo.00121.2015. View

16.

Chaanine A, Jeong D, Liang L, Chemaly E, Fish K, Gordon R . JNK modulates FOXO3a for the expression of the mitochondrial death and mitophagy marker BNIP3 in pathological hypertrophy and in heart failure. Cell Death Dis. 2012; 3:265. PMC: 3288347. DOI: 10.1038/cddis.2012.5. View

17.

Chen H, Chomyn A, Chan D . Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J Biol Chem. 2005; 280(28):26185-92. DOI: 10.1074/jbc.M503062200. View

18.

Zhou J, Dong X, Zhou Q, Wang H, Qian Y, Tian W . microRNA expression profiling of heart tissue during fetal development. Int J Mol Med. 2014; 33(5):1250-60. DOI: 10.3892/ijmm.2014.1691. View

19.

Salbaum J, Kruger C, Zhang X, Delahaye N, Pavlinkova G, Burk D . Altered gene expression and spongiotrophoblast differentiation in placenta from a mouse model of diabetes in pregnancy. Diabetologia. 2011; 54(7):1909-20. PMC: 3882064. DOI: 10.1007/s00125-011-2132-6. View

20.

Van Rooij E, Sutherland L, Liu N, Williams A, McAnally J, Gerard R . A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A. 2006; 103(48):18255-60. PMC: 1838739. DOI: 10.1073/pnas.0608791103. View